Published program data shows Dyne’s FORCE™ platform achieves enhanced exon skipping and prolonged dystrophin restoration in Duchenne in vivo mdx mouse model CureDuchenne provided funding to Dyne Therapeutics and we […]
Accessible gaming for people with Duchenne Individuals with Duchenne are living at a time when technology is helping to make the digital world more accessible and the real world more […]
Annual Austin Event Raises Funds to Find a Cure for Duchenne Muscular Dystrophy NEWPORT BEACH, Calif., (July 21, 2022) – CureDuchenne, a leading global nonprofit focused on funding and finding […]
Event Has Raised More Than $4.6 Million over the Last Decade to Find a Cure for Duchenne Muscular Dystrophy NEWPORT BEACH, Calif., (July 19, 2022) – CureDuchenne, a leading global […]
Kevin Flanigan, MD is a leading expert in the development of gene therapies for Duchenne, and the director of the Center for Gene Therapy in the Abigail Wexner Research Institute […]
Duchenne muscular dystrophy was nominated to be added to the Recommended Uniform Screening Panel (RUSP), a list of disorders that are screened for at birth. This is an important step […]
Sarepta Therapeutics Shares Clinical Data and Integrated Analysis.
Dear Duchenne Community, We are writing to provide some additional information to accompany our press release (attached) this week about the status of the rolling New Drug Application at the […]
Capricor Announces More Good News For CAP-1002
